Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LN-439A, a novel BAP1 inhibitor, suppresses the growth of basal-like breast cancer by degrading KLF5. | Acta Pharmacol Sin | 2025 | 39379684 | PubTator, text mining | PubMed |
| Different parts of the mussel Gigantidas haimaensis holobiont responded differently to deep-sea sampling stress. | Integr Zool | 2025 | 39072987 | PubTator, text mining | PubMed |
| Targeting S100A12 to Improve Angiogenesis and Accelerate Diabetic Wound Healing. | Inflammation | 2025 | 38954262 | PubTator, text mining | PubMed |
| RETRACTED: MiR-375 impairs breast cancer cell stemness by targeting the KLF5/G6PD signaling axis. | Environ Toxicol | 2025 | 38470012 | PubTator, text mining | PubMed |
| Multiomic analysis reveals cellular, transcriptomic and epigenetic changes in intestinal pouches of ulcerative colitis patients. | medRxiv | 2025 | 38014192 | PubTator, text mining | PubMed |
| The molecular determinants of phenotypic plasticity in homeostasis and neoplasia. | Cancer Heterog Plast | 2024 | 40994652 | PubTator, text mining | PubMed |
| [Spatial Organization of Chromatin of the KLF5 Gene Promoter Region in Pancreatic Ductal Adenocarcinoma Cells]. | Mol Biol (Mosk) | 2024 | 39970117 | PubTator, text mining | PubMed |
| Advancements in the Application of scRNA-Seq in Breast Research: A Review. | Int J Mol Sci | 2024 | 39769466 | PubTator, text mining | PubMed |
| KLF5 silencing restrains proliferation, invasion, migration and angiogenesis of gallbladder carcinoma cells by transcriptional regulation of PDGFA. | J Cancer Res Clin Oncol | 2024 | 39704786 | PubTator, text mining | PubMed |
| Variants of KLF5 and KLF12 were related to endometrial cancer risk in the Chinese population. | Expert Rev Mol Diagn | 2024 | 39648324 | PubTator, text mining | PubMed |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Signal Transduct Target Ther | 2024 | 39627201 | PubTator, text mining | PubMed |
| Multi-omics joint screening of biomarkers related to M2 macrophages in gastric cancer. | Discov Oncol | 2024 | 39623254 | PubTator, text mining | PubMed |
| DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosis. | Bone Res | 2024 | 39617773 | PubTator, text mining | PubMed |
| Ursolic Acid Inhibits Glycolysis of Ovarian Cancer via KLF5/PI3K/AKT Signaling Pathway. | Am J Chin Med | 2024 | 39614414 | PubTator, text mining | PubMed |
| Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer. | J Exp Clin Cancer Res | 2024 | 39614393 | PubTator, text mining | PubMed |
| Exosomes to exosome-functionalized scaffolds: a novel approach to stimulate bone regeneration. | Stem Cell Res Ther | 2024 | 39521993 | PubTator, text mining | PubMed |
| Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages. | Nat Cancer | 2024 | 39478117 | PubTator, text mining | PubMed |
| DNMT3A transcriptionally downregulated by KLF5 alleviates LPS-induced inflammatory response and promotes osteogenic differentiation in hPDLSCs. | J Appl Oral Sci | 2024 | 39476105 | PubTator, text mining | PubMed |
| Correction: Mir-381-3p aggravates ovariectomy-induced osteoporosis by inhibiting osteogenic differentiation through targeting KLF5/Wnt/βcatenin signaling pathway. | J Orthop Surg Res | 2024 | 39472966 | PubTator, text mining | PubMed |
| Massively parallel reporter assays identify enhancer elements in oesophageal Adenocarcinoma. | NAR Cancer | 2024 | 39417090 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=11